article thumbnail

Linked: Air pollution and Eczema

The Dermatology Digest

levels is associated with a doubling in eczema rates among residents, according to data from hundreds of thousands of adults published in PLOS ONE. Overall, 12,695 participants (4.4%) were diagnosed with eczema. air pollution in their zip code, people were more than twice as likely to have eczema. micrometers and smaller.)

Eczema 78
article thumbnail

SLIDESHOW: Recent Data from LEO Pharma on Chronic Hand Eczema

Dermatology Times

65% of dermatology providers acknowledge a lack of understanding of CHE, highlighting the need for improved education. 65% of dermatology providers acknowledge a lack of understanding of CHE, highlighting the need for improved education.

Eczema 36
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Addressing Overlapping Pathophysiology and Patient Burden in Atopic Dermatitis and Alopecia Areata

Dermatology Times

Things we should be considering for our different patient populations to make sure we're actually managing and counseling them adequately,” said Tiffany Mayo, MD, in an interview with Dermatology Time s.

article thumbnail

Late-Breaking Data: Flexible Dosing of Abrocitinib for AD Shows Real-World Promise

Dermatology Times

As more therapeutic options become available, insights from studies like JADE REAL will be critical in guiding evidence-based, patient-centered care in dermatology. By allowing for dynamic dose adjustments in a real-world–like setting, the study underscores the importance of individualized treatment strategies.

Eczema 67
article thumbnail

Day 1 Recap: 2025 Revolutionizing Atopic Dermatitis Conference

Dermatology Times

Road to RAD: Dermatology Times Board Member Presenters Discover the latest breakthroughs in atopic dermatitis treatment and expert insights from the RAD dermatology conference in Nashville.

article thumbnail

Road to RAD: Dermatology Times Board Member Presenters

Dermatology Times

Dermatology Times editors will be onsite at the DoubleTree Hotel in Downtown Nashville bringing you the latest insights, clinical data, and expert perspectives as they unfold.

article thumbnail

Late Breaking Data: Lebrikizumab Demonstrates Efficacy in AD Patients with Skin of Color

Dermatology Times

ADmirable is the first dedicated study to evaluate the efficacy and safety of EBGLYSS in adult and adolescent patients with AD in these patients frequently underrepresented in clinical trials," said Anabela Cardoso, MD, senior vice president of immunology medical affairs at Eli Lilly and Company, in an interview with Dermatology Times.

Eczema 74